- Advertisement -
ISLAMABAD, Nov 17 (APP):The Federal Constitutional Court on Monday directed the Drug Regulatory Authority of Pakistan (DRAP) to submit a comprehensive report on the nationwide availability of life-saving medicines and adjourned further proceedings for an indefinite period.
A three-member bench headed by Chief Justice Aminuddin Khan took up the case.
During the hearing, the petitioner informed the court that he had sought the registration of 41 life-saving drugs, of which registration for 30 medicines had been completed.
However, he said DRAP had not yet provided complete information regarding the availability of these medicines in the market.
He added that during the previous hearing, DRAP had assured the court that details of life-saving medicines would be uploaded on its website, but many of the drugs still did not appear in the online database.
DRAP’s counsel argued that prices of several medicines—particularly those used for diabetes—were being regulated, and that information regarding life-saving drugs was being updated on the website.
The court directed DRAP to submit a detailed report on the availability of the medicines across the country and adjourned the hearing indefinitely.